Dose-ranging Efficacy and Pharmacokinetics Study of Intravenous Atorvastatin in Hypercholesterolemic Patients

NCT03611010 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia
Dyslipidemias

Interventions

DRUG: Atorvastatin injection

Sponsor

Cumberland Pharmaceuticals